Effects of Jingyuankang capsules on leukocyte level in AIDS patients

Journal of Traditional Chinese Medicine

Volumn 31, Issue 1, 2011, Pages 32-35

  Jiang, Shi Qing ^a   Sun, Hong Xin ^b   Xu, Ying Min ^a   Jiang, Yan Ling ^b   Pei, Jun Wen ^c   Wang, Hong Ling ^a  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b Henan Provincial Hospital of Traditional Chinese Medicine   (China)

^c HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Clinical research; HAART therapy; HIV AIDS; Jingyuankang capsules; Leukopenia; TCM therapy

Indexed keywords

JINGYUANKANG; PLANT EXTRACT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

EID: 79956112856     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0254-6272(11)60007-1     Document Type: Article

References (6)

1. Jiang SQ, Dong SQ, Yang XK. Clinical observations on treatment of 32 HIV/AIDS patients with Jingyuankang capsule and HAART. Guangming J Chin Med 2006; 21: cover 3.
2. Health Ministry of the People's Republic of China. Standards for diagnosing and principles for treating HIV/AIDS. 2003: 5-6.
3. Zhou JC. Practicable Internal Medicine for Tumors, 2nd ed. Beijing: People's Health Press; 2005: 29-30,47-48.
4. Zhang ZN. Standards for Diagnosing Hemotopathy and for Criteria Evaluating Therapeutic Effects, 2nd ed. Tianjin: Tianjin Sci-tech Press; 1998: 162.
5. Zheng XY. Instructive Principles for Clinical Research of New TCM Drugs. Beijing: China Medical Sci-tech Press; 2002: 173.
6. State TCM Administration of the People's Republic of China. TCM Technical Plan Trial Implemented in 5 Provinces for Clinical Treatment of AIDS. Nanjing: Nanjing University Press; 2004: 26-30.